Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8


Associations of resting heart rate with endothelium-dependent vasodilation and shear rate.

Laosiripisan J, Parkhurst KL, Tanaka H.

Clin Exp Hypertens. 2017;39(2):150-154. doi: 10.1080/10641963.2016.1226890. Epub 2017 Feb 28.


Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab.

Falchook GS, Wheler JJ, Naing A, Jackson EF, Janku F, Hong D, Ng CS, Tannir NM, Lawhorn KN, Huang M, Angelo LS, Vishwamitra D, Hess K, Howard AN, Parkhurst KL, Amin HM, Kurzrock R.

Oncotarget. 2014 Nov 15;5(21):10280-92.


Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.

Falchook GS, Wheler JJ, Naing A, Piha-Paul SA, Fu S, Tsimberidou AM, Hong DS, Janku F, Zinner R, Jiang Y, Huang M, Lin Q, Parkhurst K, Kurzrock R.

Invest New Drugs. 2015 Feb;33(1):215-24. doi: 10.1007/s10637-014-0176-4. Epub 2014 Nov 4.


A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.

Falchook GS, Moulder S, Naing A, Wheler JJ, Hong DS, Piha-Paul SA, Tsimberidou AM, Fu S, Zinner R, Janku F, Jiang Y, Huang M, Parkhurst KL, Kurzrock R.

Invest New Drugs. 2015 Feb;33(1):177-86. doi: 10.1007/s10637-014-0173-7. Epub 2014 Oct 18.


Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies.

Falchook GS, Fu S, Naing A, Hong DS, Hu W, Moulder S, Wheler JJ, Sood AK, Bustinza-Linares E, Parkhurst KL, Kurzrock R.

Invest New Drugs. 2013 Oct;31(5):1192-200. doi: 10.1007/s10637-013-0003-3. Epub 2013 Aug 2.


Contribution of blood viscosity in the assessment of flow-mediated dilation and arterial stiffness.

Parkhurst KL, Lin HF, Devan AE, Barnes JN, Tarumi T, Tanaka H.

Vasc Med. 2012 Aug;17(4):231-4. doi: 10.1177/1358863X12450095.


Effects of swimming training on blood pressure and vascular function in adults >50 years of age.

Nualnim N, Parkhurst K, Dhindsa M, Tarumi T, Vavrek J, Tanaka H.

Am J Cardiol. 2012 Apr 1;109(7):1005-10. doi: 10.1016/j.amjcard.2011.11.029. Epub 2012 Jan 11.


Low flow-mediated constriction: prevalence, impact and physiological determinant.

Harrison M, Parkhurst K, Tarumi T, Lin HF, Tanaka H.

Clin Physiol Funct Imaging. 2011 Sep;31(5):394-8. doi: 10.1111/j.1475-097X.2011.01032.x. Epub 2011 May 29.


Supplemental Content

Loading ...
Support Center